EYA4 and pancreatic ductal adenocarcinoma: Our recent study demonstrated that EYA4 is silenced in pancreatic ductal adenocarcinoma (PDAC) and forced expression of EYA4 can block nuclear β-catenin inclusion and Id2 transcription to oppose PDAC development 7.